Clinical Study
Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease
Table 3
Plasma biomarkers in patients with Kawasaki disease who had a response to IVIG or were IVIG resistant.
| ||||||||||||||||||||||||||||||||||||||||||||||||
CLUSTER 1 (mg/L): plasma clusterin concentration before IVIG treatment; CLUSTER 2 (mg/L): plasma clusterin concentration after IVIG treatment; CLUSTER 12 (mg/L): CLUSTER 2 − CLUSTER 1; CLUSTER 012: CLUSTER 2/CLUSTER 1; FIB 1 (mg/dL): plasma fibrinogen concentration before IVIG treatment; FIB 2 (mg/dL): plasma fibrinogen concentration after IVIG treatment; FIB 12 (mg/dL): FIB 2 – FIB 1; FIB 012: FIB 2/FIB 1. *P < 0.05 was considered statistically significant difference. |